{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:20:57Z","timestamp":1790644857756,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Considerable overlap exists between the risk factors of dementia and cerebral small vessel disease (SVD). However, studies remain limited to older cohorts wherein pathologies of both dementia (e.g. amyloid) and SVD (e.g. white matter hyperintensities) already co-exist. In younger asymptomatic adults, we investigated differential associations and interactions of modifiable and non-modifiable inherited risk factors of (future) late-life dementia to (present-day) mid-life SVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Cognitively healthy middle-aged adults (aged 40\u201359; mean 51.2\u00a0years) underwent 3T MRI (\n                      <jats:italic>n<\/jats:italic>\n                      = 630) as part of the PREVENT-Dementia study. To assess SVD, we quantified white matter hyperintensities, enlarged perivascular spaces, microbleeds, lacunes, and computed composite scores of SVD burden and subtypes of hypertensive arteriopathy and cerebral amyloid angiopathy (CAA). Non-modifiable (inherited) risk factors were APOE4 status and parental family history of dementia. Modifiable risk factors were derived from the 2020 Lancet Commission on dementia prevention (early\/midlife: education, hypertension, obesity, alcohol, hearing impairment, head injuries). Confirmatory factor analysis (CFA) was used to evaluate the latent variables of SVD and risk factors. Structural equation modelling (SEM) of the full structural assessed associations of SVD with risk factors and APOE4*risk interaction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In SEM, the latent variable of global SVD related to the latent variable of modifiable midlife risk SVD (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      = 0.80,\n                      <jats:italic>p<\/jats:italic>\n                      = .009) but not non-modifiable inherited risk factors of APOE4 or family history of dementia. Interaction analysis demonstrated that the effect of modifiable risk on SVD was amplified in APOE4 non-carriers (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      = \u2212\u20090.31,\n                      <jats:italic>p<\/jats:italic>\n                      = .009), rather than carriers. These associations and interaction effects were observed in relation to the SVD subtype of hypertensive arteriopathy, rather than CAA. Sensitivity analyses using separate general linear models validated SEM results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Established modifiable risk factors of future (late-life) dementia related to present-day (mid-life) SVD, suggesting that early lifestyle modifications could potentially reduce rates of vascular cognitive impairment attributed to SVD, a major \u2018silent\u2019 contributor to global dementia cases. This association was amplified in APOE4 non-carriers, suggesting that lifestyle modifications could be effective even in those with genetic predisposition to dementia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-022-01095-4","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:02:52Z","timestamp":1665532972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study"],"prefix":"10.1186","volume":"14","author":[{"given":"Audrey","family":"Low","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Prats-Sedano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Stefaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Nannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Eleni","family":"Dounavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Muniz-Terrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorina","family":"Naci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Koychev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S.","family":"Markus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"1095_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689\u2013701.","journal-title":"Lancet Neurol"},{"key":"1095_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"J Attems","year":"2014","unstructured":"Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer\u2019s disease - lessons from pathology. BMC Med. 2014;12:1\u201312.","journal-title":"BMC Med."},{"key":"1095_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TLS, et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016;79:929\u201339.","journal-title":"Ann Neurol."},{"key":"1095_CR4","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.ajpath.2021.07.004","volume":"191","author":"RN Kalaria","year":"2021","unstructured":"Kalaria RN, Sepulveda-Falla D. Cerebral small vessel disease in sporadic and familial Alzheimer disease. Am J Pathol. 2021;191:1888\u2013905.","journal-title":"Am J Pathol"},{"key":"1095_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JAD-130698","volume":"38","author":"A-MM Tolppanen","year":"2014","unstructured":"Tolppanen A-MM, Ngandu T, K\u00e5reholt I, Laatikainen T, Rusanen M, Soininen H, et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimer\u2019s Dis. 2014;38:201\u20139.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1095_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.18632\/aging.102738","volume":"12","author":"Z Sun","year":"2020","unstructured":"Sun Z, Wang ZT, Sun FR, Shen XN, Xu W, Ma YH, et al. Late-life obesity is a protective factor for prodromal Alzheimer\u2019s disease: a longitudinal study. Aging (Albany NY). 2020;12:2005\u201317.","journal-title":"Aging (Albany NY)."},{"key":"1095_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","volume":"77","author":"S Debette","year":"2011","unstructured":"Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77:461\u20138.","journal-title":"Neurology."},{"key":"1095_CR8","doi-asserted-by":"publisher","first-page":"H1117","DOI":"10.1152\/ajpheart.00535.2017","volume":"314","author":"DR Jorgensen","year":"2018","unstructured":"Jorgensen DR, Shaaban CE, Wiley CA, Gianaros PJ, Mettenburg J, Rosano C. A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: An invited review. Am J Physiol Hear Circ Physiol. 2018;314:H1117\u201336.","journal-title":"Am J Physiol Hear Circ Physiol."},{"key":"1095_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neurobiolaging.2016.03.011","volume":"42","author":"DA Dickie","year":"2016","unstructured":"Dickie DA, Ritchie SJ, Cox SR, Sakka E, Royle NA, Aribisala BS, et al. Vascular risk factors and progression of white matter hyperintensities in the Lothian Birth Cohort 1936. Neurobiol Aging. 2016;42:116\u201323.","journal-title":"Neurobiol Aging."},{"key":"1095_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","volume":"19","author":"WJ Strittmatter","year":"1996","unstructured":"Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer\u2019s disease. Annu Rev Neurosci. 1996;19:53\u201377.","journal-title":"Annu Rev Neurosci."},{"key":"1095_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ajmg.b.32399","volume":"171B","author":"D Scarabino","year":"2016","unstructured":"Scarabino D, Gambina G, Broggio E, Pelliccia F, Corbo RM. Influence of family history of dementia in the development and progression of late-onset Alzheimer\u2019s disease. Am J Med Genet Part B Neuropsychiatr Genet. 2016;171B:250\u20136.","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet."},{"key":"1095_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413\u201346.","journal-title":"Lancet."},{"key":"1095_CR13","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1212\/WNL.0000000000004007","volume":"88","author":"M Pasi","year":"2017","unstructured":"Pasi M, Boulouis G, Fotiadis P, Auriel E, Charidimou A, Haley K, et al. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease. Neurology. 2017;88:2162\u20138.","journal-title":"Neurology."},{"key":"1095_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1212\/WNL.0000000000002362","volume":"86","author":"A Charidimou","year":"2016","unstructured":"Charidimou A, Boulouis G, Haley K, Auriel E, Van Etten ES, Fotiadis P, et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2016;86:505\u201311.","journal-title":"Neurology."},{"key":"1095_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1212\/WNL.0000000000003746","volume":"88","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Boulouis G, Pasi M, Auriel E, van Etten ES, Haley K, et al. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2017;88:1157\u201364.","journal-title":"Neurology."},{"key":"1095_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/01.STR.0000125859.71051.83","volume":"35","author":"FE De Leeuw","year":"2004","unstructured":"De Leeuw FE, Richard F, De Groot JC, Van Duijn CM, Hofman A, Van Gijn J, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke. 2004;35:1057\u201360.","journal-title":"Stroke"},{"key":"1095_CR17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/01.STR.30.8.1548","volume":"30","author":"C DeCarli","year":"1999","unstructured":"DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E \u03b54 and vascular disease on brain morphology in men from the NHLBI Twin Study. Stroke. 1999;30:1548\u201353.","journal-title":"Stroke"},{"key":"1095_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2012-001893","volume":"2","author":"CW Ritchie","year":"2012","unstructured":"Ritchie CW, Ritchie K. The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer\u2019s disease. BMJ Open. 2012;2:1\u20136.","journal-title":"BMJ Open."},{"issue":"8","key":"1095_CR19","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1007\/s00415-022-11061-7","volume":"269","author":"M-E Dounavi","year":"2022","unstructured":"Dounavi M-E, Newton C, Jenkins N, Mak E, Low A, Muniz-Terrera G, et al. Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study. J Neurol. 2022;269(8):4299\u2013309.","journal-title":"J Neurol"},{"key":"1095_CR20","doi-asserted-by":"crossref","unstructured":"Low A, Prats-Sedano MA, Stefaniak JD, McKiernan EF, Carter SF, Douvani M-E, et al. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study. J Neurol Neurosurg Psychiatry; 2022;0:jnnp-2021-327462.","DOI":"10.1136\/jnnp-2021-327462"},{"key":"1095_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 1987;149:351\u20136.","journal-title":"AJR Am J Roentgenol."},{"key":"1095_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000375153","volume":"39","author":"GM Potter","year":"2015","unstructured":"Potter GM, Chappell FM, Morris Z, Wardlaw JM. Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis. 2015;39:224\u201331.","journal-title":"Cerebrovasc Dis."},{"key":"1095_CR23","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","volume":"73","author":"SM Gregoire","year":"2009","unstructured":"Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73:1759\u201366.","journal-title":"Neurology."},{"key":"1095_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","journal-title":"Lancet Neurol."},{"key":"1095_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/01.WNL.0000086375.33512.53","volume":"61","author":"MJ Firbank","year":"2003","unstructured":"Firbank MJ, Minett T, O\u2019Brien JT. Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. Neurology. 2003;61:950\u20134.","journal-title":"Neurology."},{"key":"1095_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuroimage.2017.03.024","volume":"170","author":"L Griffanti","year":"2018","unstructured":"Griffanti L, Jenkinson M, Suri S, Zsoldos E, Mahmood A, Filippini N, et al. Classification and characterization of periventricular and deep white matter hyperintensities on MRI: A study in older adults. Neuroimage. 2018;170:174\u201381.","journal-title":"Neuroimage."},{"key":"1095_CR27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228\u201334.","journal-title":"Neurology."},{"key":"1095_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","volume":"8","author":"SM Greenberg","year":"2009","unstructured":"Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165\u201374.","journal-title":"Lancet Neurol."},{"key":"1095_CR29","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1161\/STROKEAHA.119.027544","volume":"51","author":"NJ Armstrong","year":"2020","unstructured":"Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, et al. Common genetic variation indicates separate causes for periventricular and deep white matter hyperintensities. Stroke. 2020;51:2111\u201321.","journal-title":"Stroke."},{"key":"1095_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/HTR.0000000000000099","volume":"29","author":"K D-O, JB C, M B, MP D, LA S, WA G.","year":"2014","unstructured":"K D-O, JB C, M B, MP D, LA S, WA G. Screening for traumatic brain injury: findings and public health implications. J Head Trauma Rehabil. 2014;29:479\u201389.","journal-title":"J Head Trauma Rehabil."},{"key":"1095_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.34172\/hpp.2020.23","volume":"10","author":"H Tutunchi","year":"2020","unstructured":"Tutunchi H, Ebrahimi-Mameghani M, Ostadrahimi A, Asghari-Jafarabadi M. What are the optimal cut-off points of anthropometric indices for prediction of overweight and obesity? Predictive validity of waist circumference, waist-to-hip and waist-to-height ratios. Heal Promot Perspect. 2020;10:142.","journal-title":"Heal Promot Perspect."},{"key":"1095_CR32","first-page":"23","volume":"8","author":"K Schermelleh-Engel","year":"2003","unstructured":"Schermelleh-Engel K, Moosbrugger H, M\u00fcller H. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res Online. 2003;8:23\u201374.","journal-title":"Methods Psychol Res Online."},{"key":"1095_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-13-92","volume":"13","author":"L Thabane","year":"2013","unstructured":"Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13:1\u201312.","journal-title":"BMC Med Res Methodol."},{"key":"1095_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jalz.2017.08.017","volume":"14","author":"JD Stefaniak","year":"2018","unstructured":"Stefaniak JD, Su L, Mak E, Sheikh-Bahaei N, Wells K, Ritchie K, et al. Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;14:253\u20138.","journal-title":"Alzheimer\u2019s Dement."},{"key":"1095_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2020.10.029","volume":"98","author":"A Low","year":"2021","unstructured":"Low A, Su L, Stefaniak JD, Mak E, Dounavi M-E, Muniz-Terrera G, et al. Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study. Neurobiol Aging. 2021;98:124\u201333.","journal-title":"Neurobiol Aging."},{"key":"1095_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1212\/WNL.0b013e31829bfda4","volume":"81","author":"S Schilling","year":"2013","unstructured":"Schilling S, DeStefano AL, Sachdev PS, Choi SH, Mather KA, DeCarli CD, et al. APOE genotype and MRI markers of cerebrovascular disease. Neurology. 2013;81:292\u2013300.","journal-title":"Neurology."},{"key":"1095_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp-2020-323894","volume":"92","author":"A Low","year":"2020","unstructured":"Low A, Mak E, Malpetti M, Passamonti L, Nicastro N, Stefaniak JD, et al. In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2020;92:45\u201352.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1095_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/brain\/awab003","volume":"144","author":"J Walsh","year":"2021","unstructured":"Walsh J, Tozer DJ, Sari H, Hong YT, Drazyk A, Williams G, et al. Microglial activation and blood\u2013brain barrier permeability in cerebral small vessel disease. Brain. 2021;144:1361\u201371.","journal-title":"Brain."},{"key":"1095_CR39","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jalz.2016.09.006","volume":"13","author":"JM Wardlaw","year":"2017","unstructured":"Wardlaw JM, Makin SJ, Vald\u00e9s Hern\u00e1ndez MC, Armitage PA, Heye AK, Chappell FM, et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. Alzheimer\u2019s Dement. 2017;13:634.","journal-title":"Alzheimer\u2019s Dement."},{"key":"1095_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00239-019-09923-2","volume":"88","author":"SG Byars","year":"2020","unstructured":"Byars SG, Voskarides K. Antagonistic pleiotropy in human disease. J Mol Evol. 2020;88:12\u201325.","journal-title":"J Mol Evol"},{"key":"1095_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3233\/JAD-181089","volume":"68","author":"CJ Smith","year":"2019","unstructured":"Smith CJ, Ashford JW, Perfetti TA. Putative survival advantages in young apolipoprotein \u025b4 carriers are associated with increased neural stress. J Alzheimers Dis. 2019;68:885\u2013923.","journal-title":"J Alzheimers Dis."},{"key":"1095_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnagi.2020.00150","volume":"12","author":"HN Yassine","year":"2020","unstructured":"Yassine HN, Finch CE. APOE alleles and diet in brain aging and Alzheimer\u2019s disease. Front Aging Neurosci. 2020;12:150.","journal-title":"Front Aging Neurosci."},{"key":"1095_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1558-5646.1957.tb02911.x","volume":"11","author":"GC Williams","year":"1957","unstructured":"Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957;11:398.","journal-title":"Evolution"},{"key":"1095_CR44","doi-asserted-by":"crossref","unstructured":"Garcia AR, Finch C, Gatz M, Kraft T, Rodriguez DE, Cummings D, et al. Apoe4 is associated with elevated blood lipids and lower levels of innate immune biomarkers in a tropical amerindian subsistence population. Elife.\u00a02021;10:e68231.","DOI":"10.7554\/eLife.68231"},{"key":"1095_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1749-6632.2002.tb04797.x","volume":"977","author":"M Yamada","year":"2002","unstructured":"Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci. 2002;977:37\u201344.","journal-title":"Ann N Y Acad Sci"},{"key":"1095_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2019.00145","volume":"11","author":"MR Caunca","year":"2019","unstructured":"Caunca MR, De Leon-Benedetti A, Latour L, Leigh R, Wright CB. Neuroimaging of cerebral small vessel disease and age-related cognitive changes. Front Aging Neurosci. 2019;11:1\u201315.","journal-title":"Front Aging Neurosci."},{"key":"1095_CR47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/genes10030222","volume":"10","author":"P Abondio","year":"2019","unstructured":"Abondio P, Sazzini M, Garagnani P, Boattini A, Monti D, Franceschi C, et al. The genetic variability of APOE in different human populations and its implications for longevity. Genes. 2019;10:222.","journal-title":"Genes"},{"key":"1095_CR48","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3174\/ajnr.A1355","volume":"30","author":"RNK Nandigam","year":"2009","unstructured":"Nandigam RNK, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: Effect of susceptibility-weighted imaging, section thickness, and field strength. Am J Neuroradiol. 2009;30:338\u201343.","journal-title":"Am J Neuroradiol"},{"key":"1095_CR49","doi-asserted-by":"publisher","first-page":"m3692","DOI":"10.1136\/bmj.m3692","volume":"371","author":"Y Pan","year":"2020","unstructured":"Pan Y, Li H, Wardlaw JM, Wang Y. A new dawn of preventing dementia by preventing cerebrovascular diseases. BMJ. 2020;371:m3692.","journal-title":"BMJ"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01095-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T11:09:00Z","timestamp":1665572940000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01095-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01095-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the London-Camberwell St Giles National Health Service Ethics Committee (REC reference: 12\/LO\/1023), which operates according to the Helsinki Declaration of 1975 (and as revised in 1983). All participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no conflicts related to this study. Unrelated to this work, J.T. O\u2019Brien has received honoraria for work as DSMB chair or member for TauRx, Axon, Eisai, has acted as a consultant for Lilly and Biogen, and has received honorarium for talks from GE Healthcare and research support from Alliance Medical and Merck.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}